Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosome + PRP + gonadotropin ovarian injection in premature ovarian failure/insufficiency
IRCT20230528058312N1Phase 2Completed
- Sponsor
- Tahoora Pharmaceutical
- Start
- Jun 2023
- Countries
- 1
01
Overview
Phase 2, single-arm trial of platelet-rich plasma in ovarian hypofunction (POI), sponsored by Tahoora Pharmaceutical. Started Jun 2023; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
ovarian hypofunction (POI)
Beyond the preview
Go deeper on IRCT20230528058312N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230528058312N1.